Supplementary Methods, Figures 1-9, Table 1 from rILYd4, a Human CD59 Inhibitor, Enhances Complement-Dependent Cytotoxicity of Ofatumumab against Rituximab-Resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia

Authors:
  • XGXiaowen Ge
    Xiaowen Ge
  • LWLin Wu
    Lin Wu
  • WHWeiguo Hu
    Weiguo Hu
  • SFStacey Fernandes
    Stacey Fernandes
  • CWChun Wang
    Chun Wang
  • XLXu Li
    Xu Li
  • JBJennifer R. Brown
    Jennifer R. Brown
  • XQXuebin Qin
    Xuebin Qin

Abstract
No abstract available